Aclaris Therapeutics (ACRS) Common Stock Issued (2016 - 2026)
Aclaris Therapeutics' Common Stock Issued was $114,000 in Q2 2026, down 99.8% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Common Stock Issued (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Aclaris Therapeutics' Common Stock Issued was $133.11 million through Jun 30, 2026; for FY2024, it came in at $74.95 million, up 179.6% from FY2023.
- Common Stock Issued shows a five-year compound annual growth rate of 224.9% (FY2019 to FY2024).
- In earlier years, Common Stock Issued was $26.81 million in FY2023 (-63.2%), $72.9 million in FY2022 (-69.6%), $239.66 million in FY2021 and $70,000 in FY2020 (-66.2%).
- The Q2 2026 figure marks the lowest quarterly Common Stock Issued since Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 743.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 247.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 87.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Aclaris Therapeutics | 638.89 Mn | 236.88 Mn | 1.29 Mn | 58.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 58.59 Mn |
| Jun 30, 2026 | 114,000.00 |
| Mar 31, 2026 | 58.03 Mn |
| Dec 31, 2024 | 74.91 Mn |
| Dec 31, 2023 | 49,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Jun 30, 2022 | 72.83 Mn |
| Mar 31, 2022 | 37,000.00 |
| Dec 31, 2021 | 238.20 Mn |
| Jun 30, 2021 | -102.31 Mn |
| Mar 31, 2021 | 103.76 Mn |
| Mar 31, 2020 | 25,000.00 |
| Dec 31, 2019 | 122,000.00 |
| Sep 30, 2019 | 82,000.00 |
| Sep 30, 2018 | 183,000.00 |
| Mar 31, 2018 | 394,000.00 |
| Sep 30, 2017 | -19.31 Mn |
| Jun 30, 2017 | 19.34 Mn |
| Mar 31, 2017 | 209,000.00 |
API Access
Aclaris Therapeutics Common Stock Issued API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-stock-issued&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-stock-issued", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-stock-issued&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();